Urinary levels of monocyte chemoattractant protein (MCP)-1 and disease activity in patients with IgA nephropathy

被引：0
|
作者：
Saitoh, A
Suzuki, Y
Takeda, M
Kubota, K
Itoh, K
Tomino, Y
机构：
[1] Juntendo Univ, Sch Med, Dept Med, Div Nephrol,Bunkyo Ku, Tokyo 113, Japan
[2] Special Reference Lab, Tokyo, Japan
[3] Kanagawa Prefectural Coll Nursing & Med Technol, Kanagawa, Japan
来源：
JOURNAL OF CLINICAL LABORATORY ANALYSIS | 1998年 / 12卷 / 01期
关键词：
MCP-1; ELISA; urine; renal histology; IgA nephropathy;
D O I：
10.1002/(SICI)1098-2825(1998)12:1<1::AID-JCLA1>3.0.CO;2-F
中图分类号：
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号：
1001 ;
摘要：
Using a quantitative sandwich ELISA, we studied 17 patients with IgA nephropathy to determine if levels of urinary monocyte chemoattractant protein-1 (MCP-1) might reflect the disease activity. The levels of urinary MCP-1 in patients with the advanced stage were significantly higher than those in patients with the mild stage of the disease, or in healthy controls. The results showed a significant correlation between the levels of urinary MCP-1 and the disease activity, i.e., levels of urinary casts and urinary protein. It was thus suggested that the measurement of urinary MCP-1 is useful in evaluating the degree of renal invanced juries and/or prognosis in patients with IgA nephropathy. (C) 1998 Wiley-Liss, Inc.
引用
收藏
页码：1 / 5
页数：5
相关论文
共 50 条
  • [21] Peptide mimics of monocyte chemoattractant protein-1 (MCP-1) with an antagonistic activity
    Kaji, M
    Ikari, M
    Hashiguchi, S
    Ito, Y
    Matsumoto, R
    Yoshimura, T
    Kuratsu, J
    Sugimura, K
    JOURNAL OF BIOCHEMISTRY, 2001, 129 (04): : 577 - 583
  • [22] The role of monocyte chemoattractant protein (MCP)-1 in infarct healing
    Dewald, O
    Ren, GF
    Klemm, C
    Koerting, A
    Winkelmann, K
    Rollins, BJ
    Entman, ML
    Frangogiannis, NG
    CIRCULATION, 2004, 110 (17) : 28 - 28
  • [23] Significance of Urinary Monocyte Chemoattractant Protein-1 in Early Detection of Nephropathy in Type 2 Diabetic Patients
    Nabih, Mona I.
    El-Mazny, Ahmed
    Mohamed, Nadia A.
    El-Shehaby, Amal R.
    LIFE SCIENCE JOURNAL-ACTA ZHENGZHOU UNIVERSITY OVERSEAS EDITION, 2013, 10 (01): : 3030 - 3039
  • [24] HUMAN MONOCYTE CHEMOATTRACTANT PROTEIN-1 (MCP-1)
    LEONARD, EJ
    YOSHIMURA, T
    IMMUNOLOGY TODAY, 1990, 11 (03): : 97 - 101
  • [25] Monocyte Chemoattractant Protein 1 (MCP-1) in obesity and diabetes
    Panee, Jun
    CYTOKINE, 2012, 60 (01) : 1 - 12
  • [26] Monocyte Chemoattractant Protein-1 (MCP-1): An Overview
    Deshmane, Satish L.
    Kremlev, Sergey
    Amini, Shohreh
    Sawaya, Bassel E.
    JOURNAL OF INTERFERON AND CYTOKINE RESEARCH, 2009, 29 (06): : 313 - 326
  • [27] Urinary Monocyte Chemoattractant Protein-1 in Patients With Alport Syndrome
    Kashtan, Clifford
    Schachter, Asher
    Klickstein, Lloyd
    Liu, Xin
    Jennings, Lori
    Finkel, Nancy
    KIDNEY INTERNATIONAL REPORTS, 2022, 7 (07): : 1112 - 1114
  • [28] Levels of Urinary Complement Factor H in Patients with IgA Nephropathy are Closely Associated with Disease Activity
    Zhang, J. -J.
    Jiang, L.
    Liu, G.
    Wang, S. -X.
    Zou, W. -Z.
    Zhang, H.
    Zhao, M. -H.
    SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 2009, 69 (05) : 457 - 464
  • [29] Estimation of Monocyte Chemoattractant Protein-1 (MCP-1) Levels as an Inflammatory Cytokine in Chronic Generalized Periodontitis Patients
    Gupta, Anushri
    Srivastava, Sumedha
    Kalburgi, Veena
    Dubey, Ashutosh
    Nimmala, Sai Sri Harsha
    Gupta, Meghaanshu
    JOURNAL OF YOUNG PHARMACISTS, 2022, 14 (04) : 430 - 434
  • [30] Urinary Protein Biomarkers for Assessing Disease Activity and Chronicity in IgA Nephropathy
    Post, Tomas
    Rother, Nils
    Pieterse, Elmar
    Rood, Ilse
    van Emst, Liesbeth
    Joosten, Leo
    Hilbrands, Luuk
    Rodriguez, Julio Saez
    Barratt, Jonathan
    Duivenvoorden, Raphael
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2024, 39
12345